XFCT-MRI hybrid multimodal contrast agents for complementary imaging
Giovanni Marco Saladino, Carmen Vogt, Bertha Brodin, Kian Shaker, Nuzhet I. Kilic, Kenth Andersson, Marie Arsenian‐Henriksson, Muhammet S. Toprak, Hans M. Hertz
Abstract
preclinical studies demonstrate the possibility of correlative bioimaging with these contrast agents. The complementarity allows accurate localization, provided by the high contrast of the soft tissues in MRI combined with the elemental selectivity of XFCT, leading to NP detection with high specificity and resolution. We envision that this multimodal imaging could find future applications for early tumor diagnosis, improved long-term treatment monitoring, and enhanced radiotherapy planning.
Topics & Concepts
Magnetic resonance imagingMaterials scienceNuclear magnetic resonanceContrast (vision)Dual modeNanoparticleBiomedical engineeringNanotechnologyRadiologyMedicineComputer sciencePhysicsEngineeringArtificial intelligenceAerospace engineeringLanthanide and Transition Metal ComplexesNanoplatforms for cancer theranosticsMedical Imaging Techniques and Applications